NeuroGeno3D: A unified clinical decision support system integrating structural biology, molecular interpretation, and clinical evidence for precision neuro-oncology
- 29 September 2026
- journal article
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 154
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- The emerging role of intraoperative nanopore sequencing on the neurosurgical strategy in paediatric embryonal brain tumoursChild's Nervous System, 2026
- OS06.7.A PLATFORM-AGNOSTIC METHYLATION CLASSIFICATION OF 184 CLASSES OF CNS TUMOURSNeuro-Oncology, 2024
- Ultra-fast deep-learned CNS tumour classification during surgeryNature, 2023
- Nanopore sequencing technology and its applicationsMedcomm, 2023
- Machine learning for cryosection pathology predicts the 2021 WHO classification of gliomaMed, 2023
- Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guidelineNeuro-Oncology, 2023
- Artificial-intelligence-based molecular classification of diffuse gliomas using rapid, label-free optical imagingNature Medicine, 2023
- DNA methylation-based classification of central nervous system tumoursNature, 2018
- Development of the CNS TAP tool for the selection of precision medicine therapies in neuro-oncologyJournal of Neuro-Oncology, 2017
- Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse GliomaCell, 2016